Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -PLN 13.1B, followed by BridgeBio Pharma (-PLN 8.4B) and Cytokinetics (-PLN 2.6B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-PLN 13.1B
- Median
- PLN 3.5B
- Combined market value
- PLN 20.6T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -PLN 13.1B | PLN 2.07T | PLN 1,168.99 | 0.61% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -PLN 8.4B | PLN 60.8B | PLN 312.33 | 1.25% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -PLN 2.6B | PLN 29.4B | PLN 211.15 | 1.78% up | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -PLN 824.7M | PLN 20.3B | PLN 243.49 | 0.43% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -PLN 725.6M | PLN 71.5B | PLN 1,089.50 | 0.02% up | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -PLN 486.1M | PLN 21.5B | PLN 509.38 | 0.94% up | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -PLN 284.3M | PLN 30.1B | PLN 86.44 | 1.89% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | PLN 354.6M | PLN 28.5B | PLN 542.46 | 0.66% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | PLN 461.2M | PLN 19.6B | PLN 203.93 | 0.64% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 558.6M | PLN 32.4B | PLN 467.27 | 0.24% down | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | PLN 1.3B | PLN 24.1B | PLN 369.59 | 0.07% up | 31% up | ||
| 12 | ErascaERAS · Health Care | PLN 1.3B | PLN 19.1B | PLN 54.38 | 2.52% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | PLN 1.3B | PLN 16.2B | PLN 118.67 | 0.56% up | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 1.9B | PLN 24.8B | PLN 175.69 | 1.74% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | PLN 1.9B | PLN 26.7B | PLN 393.67 | 1.75% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | PLN 2B | PLN 18.3B | PLN 110.12 | 1.70% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | PLN 2B | PLN 19.9B | PLN 353.34 | 1.14% up | 113% up | ||
| 18 | ABIVAXABVX · Health Care | PLN 2B | PLN 29.5B | PLN 337.25 | 2.27% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.1B | PLN 18.3B | PLN 166.99 | 1.11% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.3B | PLN 30.5B | PLN 388.04 | 1.58% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.4B | PLN 39.2B | PLN 1,688.57 | 0.38% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.5B | PLN 33B | PLN 505.99 | 1.05% up | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | PLN 2.6B | PLN 19.8B | PLN 113.87 | 1.80% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | PLN 2.6B | PLN 30.8B | PLN 281.50 | 0.02% up | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | PLN 2.6B | PLN 38.8B | PLN 256.82 | 1.96% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | PLN 2.6B | PLN 36.5B | PLN 45.59 | 6.37% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | PLN 2.9B | PLN 36.6B | PLN 385.51 | 2.31% up | 286% up | ||
| 28 | InsmedINSM · Health Care | PLN 3B | PLN 107.4B | PLN 489.74 | 0.06% up | 40% down | ||
| 29 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.8B | PLN 634.38 | 0.14% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | PLN 3.2B | PLN 84B | PLN 626.97 | 0.26% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.5B | PLN 34.9B | PLN 1,248.79 | 1.92% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | PLN 4B | PLN 12.8B | PLN 65.99 | 1.99% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | PLN 4.1B | PLN 23.8B | PLN 1,190.43 | 0.87% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | PLN 7.3B | PLN 31.3B | PLN 186.19 | 1.99% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | PLN 13.4B | PLN 136.8B | PLN 336.69 | 0.41% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 16.1B | PLN 50.1B | PLN 60.15 | 1.18% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 17.3B | PLN 62.6B | PLN 975.37 | 0.88% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | PLN 17.5B | PLN 186.4B | PLN 1,632.24 | 1.67% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | PLN 18.2B | PLN 113.9B | PLN 157.21 | 1.11% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | PLN 23.5B | PLN 128.2B | PLN 207.86 | 0.40% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | PLN 23.5B | PLN 23.5B | PLN 34.54 | 0.35% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | PLN 24.4B | PLN 46.1B | PLN 238.22 | 1.37% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | PLN 26.3B | PLN 52.8B | PLN 105.72 | 1.82% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | PLN 28.5B | PLN 99.3B | PLN 2,331.20 | 0.63% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 31.8B | PLN 200.9B | PLN 172.19 | 0.59% up | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | PLN 39B | PLN 159.1B | PLN 276.66 | 0.29% up | 78% up | ||
| 47 | ViatrisVTRS · Health Care | PLN 59.1B | PLN 95.3B | PLN 83.12 | 1.20% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | PLN 74.2B | PLN 498.1B | PLN 243.67 | 1.12% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | PLN 75B | PLN 550.9B | PLN 2,173.03 | 1.28% up | 27% up | ||
| 50 | GSKGSK · Health Care | PLN 87.3B | PLN 395.7B | PLN 197.41 | 0.18% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | PLN 106.6B | PLN 5.01T | PLN 5,630.02 | 0.98% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | PLN 115.7B | PLN 711.5B | PLN 161.43 | 1.25% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | PLN 125.5B | PLN 399.6B | PLN 3,863.07 | 0.42% up | 36% up | ||
| 54 | NovartisNVS · Health Care | PLN 185.3B | PLN 1.19T | PLN 631.93 | 1.13% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | PLN 186.9B | PLN 276B | PLN 86.40 | 0.60% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | PLN 195.5B | PLN 1.12T | PLN 724.63 | 1.02% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | PLN 209.4B | PLN 729.5B | PLN 421.22 | 0.15% up | 17% down | ||
| 58 | Merck & CoMRK · Health Care | PLN 211.3B | PLN 1.4T | PLN 568.55 | 1.27% down | 51% up | ||
| 59 | SanofiSNY · Health Care | PLN 318.1B | PLN 458.7B | PLN 191.03 | 0.06% up | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | PLN 327.5B | PLN 2.68T | PLN 1,113.44 | 0.53% down | 38% up | ||
| 61 | PfizerPFE · Health Care | PLN 347.3B | PLN 648B | PLN 113.69 | 0.58% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0166 PLN).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-PLN 13.1B), BridgeBio Pharma (-PLN 8.4B) and Cytokinetics (-PLN 2.6B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of PLN 20.6T as of 18 Nov 2026, 15:06 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.